Dr Elizabeth A Blazick, MD - Medicare Vascular Surgery in Portland, ME

Dr Elizabeth A Blazick, MD is a medicare enrolled "Surgery" physician in Portland, Maine. She went to University Of South Florida College Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Vascular Surgery. She is a member of the group practice Vascular Care Group Maine Llc and her current practice location is 887 Congress St, Suite 400, Portland, Maine. You can reach out to her office (for appointments etc.) via phone at (207) 662-3714.

Dr Elizabeth A Blazick is licensed to practice in Maine (license number MD20129) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1548465123.

Contact Information

Dr Elizabeth A Blazick, MD
887 Congress St, Suite 400,
Portland, ME 04102
(207) 662-3714
Not Available



Physician's Profile

Full NameDr Elizabeth A Blazick
GenderFemale
SpecialityVascular Surgery
Experience17 Years
Location887 Congress St, Portland, Maine
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Elizabeth A Blazick attended and graduated from University Of South Florida College Of Medicine in 2007
  NPI Data:
  • NPI Number: 1548465123
  • Provider Enumeration Date: 06/15/2007
  • Last Update Date: 05/21/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 2567616600
  • Enrollment ID: I20140708000699

Medical Identifiers

Medical identifiers for Dr Elizabeth A Blazick such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1548465123NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery L-231914 (Massachusetts)Secondary
208600000XSurgery MD20129 (Maine)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Northern Light Mercy HospitalPortland, MEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Vascular Care Group Maine Llc60022799324

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Elizabeth A Blazick allows following entities to bill medicare on her behalf.
Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104921535
PECOS PAC ID: 9335043967
Enrollment ID: O20040331000274

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more Medical News

› Verified 4 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285738310
PECOS PAC ID: 9335043967
Enrollment ID: O20040525000396

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more Medical News

› Verified 4 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790265502
PECOS PAC ID: 7517860588
Enrollment ID: O20040701000166

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more Medical News

› Verified 4 days ago

Entity NameVascular Care Group Maine Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1053019588
PECOS PAC ID: 6002279932
Enrollment ID: O20230825000535

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Elizabeth A Blazick is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Elizabeth A Blazick, MD
301c Us Route One,
Scarborough, ME 04074

Ph: (207) 396-8600
Dr Elizabeth A Blazick, MD
887 Congress St, Suite 400,
Portland, ME 04102

Ph: (207) 662-3714

News Archive

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

Reflux surgery challenged for smallest children

US physicians have raised concerns over the diagnosis and treatment of gastroesophageal reflux disease in small children, especially among infants for whom regurgitation is normal and likely to resolve with conservative treatment

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

Concentrated high-protein liquid fortifier boosts ICU babies' growth

Breast milk fortified with an ultraconcentrated high-protein liquid increases growth and is well-tolerated by preterm babies in comparison with a lower-protein enriched powder alternative, research shows.

New syndicated report covers the use of DMAs for treatment of MS published

BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends: Multiple Sclerosis. This report covers the use of disease-modifying agents for the treatment of multiple sclerosis, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth and expected future use.

Read more News

› Verified 4 days ago


Surgery Doctors in Portland, ME

Virginia A Eddy, MD
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 887 Congress St., Portland, ME 04102
Phone: 207-774-2311    
Leslie S Wu, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 887 Congress St, Suite 400, Portland, ME 04102
Phone: 207-774-6368    Fax: 207-774-9388
Dr. Benjamin Lincoln Russell, DO
Surgery
Medicare: Medicare Enrolled
Practice Location: 195 Fore River Pkwy, Suite 420, Portland, ME 04102
Phone: 207-553-6500    Fax: 207-553-6520
Dr. Forest Raymond Sheppard, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 887 Congress St Ste 210, Portland, ME 04102
Phone: 207-774-6368    Fax: 207-774-9388
Dr. Stacey Anne Rotta, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 887 Congress St, Portland, ME 04102
Phone: 207-774-6368    
Dr. Laura Teresa Withers, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 887 Congress St Ste 210, Portland, ME 04102
Phone: 207-774-2381    
Ms. Daly Anne Johnson, PA-C
Surgery
Medicare: Medicare Enrolled
Practice Location: 22 Bramhall St, Portland, ME 04102
Phone: 207-662-0111    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.